<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jacobs HIL</submitter><funding>NIA NIH HHS</funding><funding>National Institutes of Health</funding><funding>Alzheimer&amp;apos;s Association</funding><funding>National Institute on Aging</funding><funding>NIH HHS</funding><pagination>169-180</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9481982</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(1)</volume><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Autopsy studies recognize the locus coeruleus (LC) as one of the first sites accumulating tau in Alzheimer's disease (AD). Recent AD work related in vivo LC magnetic resonance imaging (MRI) integrity to tau and cognitive decline; however, relationships of LC integrity to age, tau, and cognition in autosomal dominant AD (ADAD) remain unexplored.&lt;h4>Methods&lt;/h4>We associated LC integrity (3T-MRI) with estimated years of onset, cortical amyloid beta, regional tau (positron emission tomography [PET]) and memory (Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Word-List-Learning) among 27 carriers and 27 non-carriers of the presenilin-1 (PSEN1) E280A mutation. Longitudinal changes between LC integrity and tau were evaluated in 10 carriers.&lt;h4>Results&lt;/h4>LC integrity started to decline at age 32 in carriers, 12 years before clinical onset, and 20 years earlier than in sporadic AD. LC integrity was negatively associated with cortical tau, independent of amyloid beta, and predicted precuneus tau increases. LC integrity was positively associated with memory.&lt;h4>Discussion&lt;/h4>These findings support LC integrity as marker of disease progression in preclinical ADAD.</pubmed_abstract><journal>Alzheimer's &amp; dementia : the journal of the Alzheimer's Association</journal><pubmed_title>Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.</pubmed_title><pmcid>PMC9481982</pmcid><funding_grant_id>P50AG005134</funding_grant_id><funding_grant_id>R01 AG054671</funding_grant_id><funding_grant_id>P50 AG005134</funding_grant_id><funding_grant_id>R01 AG062559</funding_grant_id><funding_grant_id>R21 AG074220</funding_grant_id><funding_grant_id>DP5OD019833</funding_grant_id><funding_grant_id>P30 AG062421</funding_grant_id><funding_grant_id>R01AG054671</funding_grant_id><funding_grant_id>DP5 OD019833</funding_grant_id><funding_grant_id>U19AG10483</funding_grant_id><funding_grant_id>P01 AG036694</funding_grant_id><funding_grant_id>R01 AG068062</funding_grant_id><funding_grant_id>U19 AG010483</funding_grant_id><funding_grant_id>R01AG068062</funding_grant_id><funding_grant_id>U01AG024904</funding_grant_id><funding_grant_id>R01AG046396</funding_grant_id><funding_grant_id>2019‐AARF‐644631</funding_grant_id><funding_grant_id>R01AG027435</funding_grant_id><funding_grant_id>P01AG036694</funding_grant_id><funding_grant_id>R01AG062559</funding_grant_id><funding_grant_id>U01 AG024904</funding_grant_id><funding_grant_id>R01 AG027435</funding_grant_id><funding_grant_id>R21AG074220</funding_grant_id><funding_grant_id>R01 AG046396</funding_grant_id><pubmed_authors>Becker JA</pubmed_authors><pubmed_authors>Engels-Dominguez N</pubmed_authors><pubmed_authors>Sanchez JS</pubmed_authors><pubmed_authors>Vila-Castelar C</pubmed_authors><pubmed_authors>Jacobs HIL</pubmed_authors><pubmed_authors>Kwong K</pubmed_authors><pubmed_authors>Johnson KA</pubmed_authors><pubmed_authors>Sperling RA</pubmed_authors><pubmed_authors>Quiroz YT</pubmed_authors><pubmed_authors>Ramirez-Gomez L</pubmed_authors><pubmed_authors>Lopera F</pubmed_authors><pubmed_authors>Baena A</pubmed_authors><pubmed_authors>Munera D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Waning locus coeruleus integrity precedes cortical tau accrual in preclinical autosomal dominant Alzheimer's disease.</name><description>&lt;h4>Introduction&lt;/h4>Autopsy studies recognize the locus coeruleus (LC) as one of the first sites accumulating tau in Alzheimer's disease (AD). Recent AD work related in vivo LC magnetic resonance imaging (MRI) integrity to tau and cognitive decline; however, relationships of LC integrity to age, tau, and cognition in autosomal dominant AD (ADAD) remain unexplored.&lt;h4>Methods&lt;/h4>We associated LC integrity (3T-MRI) with estimated years of onset, cortical amyloid beta, regional tau (positron emission tomography [PET]) and memory (Consortium to Establish a Registry for Alzheimer's Disease (CERAD) Word-List-Learning) among 27 carriers and 27 non-carriers of the presenilin-1 (PSEN1) E280A mutation. Longitudinal changes between LC integrity and tau were evaluated in 10 carriers.&lt;h4>Results&lt;/h4>LC integrity started to decline at age 32 in carriers, 12 years before clinical onset, and 20 years earlier than in sporadic AD. LC integrity was negatively associated with cortical tau, independent of amyloid beta, and predicted precuneus tau increases. LC integrity was positively associated with memory.&lt;h4>Discussion&lt;/h4>These findings support LC integrity as marker of disease progression in preclinical ADAD.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-04T07:44:53.38Z</modification><creation>2025-04-04T07:44:53.38Z</creation></dates><accession>S-EPMC9481982</accession><cross_references><pubmed>35298083</pubmed><doi>10.1002/alz.12656</doi></cross_references></HashMap>